March 16, 2020 / 12:02 PM / 23 days ago

BRIEF-Aurinia Pharmaceuticals Initiates Rolling Submission Of A New Drug Application To The U.S. FDA For Voclosporin

March 16 (Reuters) - Aurinia Pharmaceuticals Inc:

* AURINIA PHARMACEUTICALS INITIATES ROLLING SUBMISSION OF A NEW DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR VOCLOSPORIN IN THE TREATMENT OF LUPUS NEPHRITIS

* AURINIA PHARMACEUTICALS - REMAINS ON TRACK TO COMPLETE SUBMISSION OF NDA FOR VOCLOSPORIN BY END OF Q2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below